ストックスクリーナーアプリを入手
11.70
2.82%
-0.34
アフターアワーズ：
11.70
Anbio Biotechnology (NNNN) 最新ニュース
Top 3 Health Care Stocks That May Rocket Higher In July - Benzinga
Top 3 health care stocks you'll regret missing in Q2 - MSN
Price to book forward of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Price to earnings forward of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Enterprise value to revenue forward of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Price to earnings forward of Anbio Biotechnology Class A – FWB:N3B - TradingView
Anbio Biotechnology (NNNN) Stock Price Today - CoinMarketCap
NNNN PE Ratio & Valuation, Is NNNN Overvalued - Intellectia AI
Anbio Biotechnology (NNNN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anbio Biotechnology (NNNN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anbio Biotechnology Soars After Surprise Media Spotlight - TipRanks
Anbio Biotechnology (NNNN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anbio Biotechnology (NNNN) Institutional Confidence - TradingKey
Anbio Biotechnology (NNNN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anbio Biotechnology (NNNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga
Anbio Biotechnology (NNNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anbio Biotechnology (NNNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anbio Biotechnology (NNNN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anbio Biotechnology Soars as Geopolitics Ignite Rebound - TipRanks
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Anbio Biotechnology (NNNN) director ZHANG MICHAEL W.C files initial Form 3 - Stock Titan
Director David H. Hsu files initial Form 3 at Anbio Biotechnology (NNNN) - Stock Titan
Why Anbio Biotechnology Shares Keep Sinking Today - TipRanks
Anbio Biotechnology (NNNN) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks
Anbio’s Stock Has Been On A Wild Run Since Its IPO - Finimize
Anbio Biotechnology (NNNN) Faces Sharp Pullback: Key Levels and Market Sentiment After 14.88% DeclinePercent Above MA - newsline.com
Anbio Biotechnology (NNNN) Drops 7.2% as Selling Pressure IntensifiesOpening Range Breakout - newsline.com
Why Anbio Biotechnology Class A Stock Is Sliding - TipRanks
Why Anbio Biotechnology NNNN Shares Are Surging Now - TipRanks
Why Anbio Biotechnology Shares Are Tumbling Today - TipRanks
Anbio Biotechnology Holds Steady Near $34.41 as Trading Volume Remains ModerateThrowback Trade - The Legal Advocate
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast and Price Target 2026 - MarketBeat
NNNNAnbio Biotechnology Stock Price and Quote - Finviz
Anbio Biotechnology (NNNN) Holds Near Support as Selling Pressure ModeratesAAII Bearish - newsline.com
Assessing Anbio Biotechnology (NNNN) Valuation After Strong Recent Share Price Momentum - simplywall.st
Anbio Biotechnology (NNNN) Share Price Forecast & Price Target - Investing.com UK
Why Anbio Biotechnology Shares Are Tumbling Now - TipRanks
Anbio Biotechnology Shareholders Approve Sweeping Capital and Governance Changes - TipRanks
Control shifts as Anbio (NNNN) boosts Class B voting power - Stock Titan
Why Anbio Biotechnology Shares Won’t Stop Climbing - TipRanks
Uncovering 3 Undiscovered Gems in the US Market - Yahoo Finance
Top Hemab Therapeutics (COAG) Competitors 2026 - MarketBeat
TradingKey - TradingKey
Number of shareholders of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Why are smart money investors paying attention to Anbio (NNNN)? (Momentum Fading) 2026-05-07Overvalued Stocks - Newser
Hemab Therapeutics Hldgs (COAG) Stock Analysis Report | Financials & Insights - Benzinga
1.24%
2.13%
大文字化:
|
ボリューム (24 時間):